AMARIN CORP PLC\UK Debt Instrument, Increase (Decrease), Net
AMARIN CORP PLC\UK (AMRN) reported Debt Instrument, Increase (Decrease), Net of -$816.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet · last filed 2014-11-06
- 2014-09-30: Debt Instrument, Increase (Decrease), Net 9 month -$816.00K.
- 2013-09-30: Debt Instrument, Increase (Decrease), Net 9 month -$8.38M.
| Period end | Debt Instrument, Increase (Decrease), Net 9 month |
|---|---|
| 2014-09-30 | -$816.00K 10-Q · filed 2014-11-06 |
| 2013-09-30 | -$8.38M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |